Yulong Chen, Mingliang Zhang, Weixia Li, Xiaoyan Wang, Xiaofei Chen, Yali Wu, Hui Zhang, Liuqing Yang, Bing Han & Jinfa Tang. (2023) Drug repurposing based on the similarity gene expression signatures to explore for potential indications of quercetin: a case study of multiple sclerosis. Frontiers in Chemistry 11.
Crossref
Carmen Martinez-PazEmilio García-Cabrera & Ángel Vilches-Arenas. (2023) Effectiveness and Safety of Cannabinoids as an Add-On Therapy in the Treatment of Resistant Spasticity in Multiple Sclerosis: A Systematic Review. Cannabis and Cannabinoid Research 8:4, pages 580-588.
Crossref
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Saneela Tahseen & Shahid Bashir. 2023. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
187
216
.
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar & Shahid Bashir. 2023. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases
147
169
.
Gurjit Kaur Bhatti, Harsh Vikram Singh, Eva Sharma, Abhishek Sehrawat, Jayapriya Mishra, Umashanker Navik, P. Hemachandra Reddy & Jasvinder Singh Bhatti. 2023. Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders. Treatments, Nutraceuticals, Supplements, and Herbal Medicine in Neurological Disorders
453
482
.
Ana I Fraguas-Sánchez & Ana I. Torres-Suárez. 2023. Current Applications, Approaches, and Potential Perspectives for Hemp. Current Applications, Approaches, and Potential Perspectives for Hemp
407
445
.
David Myland Kaufman, Howard L. Geyer, Mark J. Milstein & Jillian L. Rosengard. 2023. Kaufman's Clinical Neurology for Psychiatrists. Kaufman's Clinical Neurology for Psychiatrists
344
364
.
Ricardo Lacava Bailone, Hirla Costa Silva Fukushima, Luis Kluwe de Aguiar & Ricardo Carneiro Borra. (2022) The endocannabinoid system in zebrafish and its potential to study the effects of Cannabis in humans. Laboratory Animal Research 38:1.
Crossref
Grace Clouse, Samantha Penman, Michael Hadjiargyrou, David E. Komatsu & Panayotis K. Thanos. (2022) Examining the role of cannabinoids on osteoporosis: a review. Archives of Osteoporosis 17:1.
Crossref
Erica Costantini, Eva Masciarelli, Laura Casorri, Marco Di Luigi & Marcella Reale. (2022) Medicinal herbs and multiple sclerosis: Overview on the hard balance between new therapeutic strategy and occupational health risk. Frontiers in Cellular Neuroscience 16.
Crossref
Heidrun Potschka, Sofie F.M. Bhatti, Andrea Tipold & Stephanie McGrath. (2022) Cannabidiol in canine epilepsy. The Veterinary Journal, pages 105913.
Crossref
John M. Purcell, Tija M. Passley & Joerg R. Leheste. (2022) The cannabidiol and marijuana research expansion act: Promotion of scientific knowledge to prevent a national health crisis. The Lancet Regional Health - Americas 14, pages 100325.
Crossref
Arash Salehi, Keely Puchalski, Yalda Shokoohinia, Behzad Zolfaghari & Sedigheh Asgary. (2022) Differentiating Cannabis Products: Drugs, Food, and Supplements. Frontiers in Pharmacology 13.
Crossref
Sara L. MacPhail, Miguel A. Bedoya-Pérez, Rhys Cohen, Vicki Kotsirilos, Iain S. McGregor & Elizabeth A. Cairns. (2022) Medicinal Cannabis Prescribing in Australia: An Analysis of Trends Over the First Five Years. Frontiers in Pharmacology 13.
Crossref
Mona Khoury, Idan Cohen & Gil Bar-Sela. (2022) “The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained. Pharmaceutics 14:2, pages 389.
Crossref
Fraser SmithFraser Smith. 2022. Naturopathic Medicine. Naturopathic Medicine
225
413
.
Morteza Abyadeh, Vivek Gupta, Joao A. Paulo, Veer Gupta, Nitin Chitranshi, Angela Godinez, Danit Saks, Mafruha Hasan, Ardeshir Amirkhani, Matthew McKay, Ghasem H. Salekdeh, Paul A. Haynes, Stuart L. Graham & Mehdi Mirzaei. (2021) A Proteomic View of Cellular and Molecular Effects of Cannabis. Biomolecules 11:10, pages 1411.
Crossref
Edgar Carnero Contentti, Pablo A. López, Juan Criniti, Juan Pablo Pettinicchi, Dario Tavolini, Carolina Mainella, Santiago Tizio, Verónica Tkachuk, Berenice Silva, Alejandro Caride, Juan I. Rojas & Ricardo Alonso. (2021) Use of cannabis in patients with multiple sclerosis from Argentina. Multiple Sclerosis and Related Disorders 51, pages 102932.
Crossref
Esraa Aly & Willias Masocha. (2021) Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review. IBRO Neuroscience Reports 10, pages 109-118.
Crossref
Antonella Conte & Carlos Vila Silván. (2021) Review of Available Data for the Efficacy and Effectiveness of Nabiximols Oromucosal Spray (Sativex®) in Multiple Sclerosis Patients with Moderate to Severe Spasticity. Neurodegenerative Diseases 21:3-4, pages 55-62.
Crossref
Fotini Moschona, Ioanna Savvopoulou, Maria Tsitopoulou, Despoina Tataraki & Gerasimos Rassias. (2020) Epoxide Syntheses and Ring-Opening Reactions in Drug Development. Catalysts 10:10, pages 1117.
Crossref